“…Therefore, such lncRNAs are potential and key players in cancer and understanding their expression level in GBM can greatly help in developing a reliable prognostic and diagnostic tool in GBM. Taking everything together, it appears that lncRNAs are reliable biomarkers in GBM and researchers have focused on developing signatures based on the most dysregulated lncRNAs for diagnosis and prognosis of GBM [ 133 , [172] , [173] , [174] , [175] , [176] , [177] , [178] , [179] , [180] ]. Table 2 provides a summary of lncRNAs involved in regulating GBM progression.…”